These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22702645)

  • 21. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes.
    Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y
    J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic control.
    Šoupal J; Škrha J; Fajmon M; Horová E; Mráz M; Škrha J; Prázný M
    Diabetes Technol Ther; 2014 Apr; 16(4):198-203. PubMed ID: 24401008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
    Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
    Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
    Ludwiczek O; Kaser A; Tilg H
    Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes.
    Zoppini G; Faccini G; Muggeo M; Zenari L; Falezza G; Targher G
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3805-8. PubMed ID: 11502815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM).
    Zorena K; Kula M; Malinowska E; Raczyńska D; Myśliwiec M; Raczyńska K
    Hum Immunol; 2013 Jan; 74(1):75-81. PubMed ID: 23073299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and Urinary Orosomucoid in Young Patients With Type 1 Diabetes: A Link Between Inflammation, Microvascular Complications, and Subclinical Atherosclerosis.
    El-Beblawy NM; Andrawes NG; Ismail EA; Enany BE; El-Seoud HS; Erfan MA
    Clin Appl Thromb Hemost; 2016 Nov; 22(8):718-726. PubMed ID: 26975878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children.
    Talat MA; Sherief LM; El-Saadany HF; Rass AA; Saleh RM; Sakr MM
    J Clin Res Pediatr Endocrinol; 2016 Dec; 8(4):399-404. PubMed ID: 27353561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between glycemic control and platelet activity in type 2 diabetes mellitus.
    Demirtunc R; Duman D; Basar M; Bilgi M; Teomete M; Garip T
    J Diabetes Complications; 2009; 23(2):89-94. PubMed ID: 18358749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator inhibitor-1 (PAI-1) in children and adolescents with type 1 diabetes mellitus: relation to diabetic micro-vascular complications and carotid intima media thickness.
    Adly AA; Elbarbary NS; Ismail EA; Hassan SR
    J Diabetes Complications; 2014; 28(3):340-7. PubMed ID: 24581943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetes.
    Neubauer H; Setiadi P; Günesdogan B; Pinto A; Börgel J; Mügge A
    Diabet Med; 2010 Apr; 27(4):384-90. PubMed ID: 20536508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes.
    Gibbons CH; Goebel-Fabbri A
    Curr Diab Rep; 2017 Jul; 17(7):48. PubMed ID: 28526993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease.
    Marx N; Imhof A; Froehlich J; Siam L; Ittner J; Wierse G; Schmidt A; Maerz W; Hombach V; Koenig W
    Circulation; 2003 Apr; 107(15):1954-7. PubMed ID: 12695287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome--the Chennai Urban Rural Epidemiology Study.
    Gokulakrishnan K; Deepa R; Mohan V; Gross MD
    Metabolism; 2006 Feb; 55(2):237-42. PubMed ID: 16423632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications.
    Herman WH; Aubert RE; Engelgau MM; Thompson TJ; Ali MA; Sous ES; Hegazy M; Badran A; Kenny SJ; Gunter EW; Malarcher AM; Brechner RJ; Wetterhall SF; DeStefano F; Smith PJ; Habib M; abd el Shakour S; Ibrahim AS; el Behairy EM
    Diabet Med; 1998 Dec; 15(12):1045-51. PubMed ID: 9868980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Microvascular complications in pancreatic diabetes].
    Gasiorowska A; Czupryniak L; Małecka-Panas E; Wiśniewska-Jarosińska M; Drzewoski J
    Pol Arch Med Wewn; 2001 Jun; 105(6):469-74. PubMed ID: 11865577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated circulating CD40L concentrations in patients with systemic sclerosis.
    Komura K; Sato S; Hasegawa M; Fujimoto M; Takehara K
    J Rheumatol; 2004 Mar; 31(3):514-9. PubMed ID: 14994397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.